1-7 of 7
Hideho Okada
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Immunotherapy of Primary Brain Tumors: Facts and Hopes

Robin A. Buerki, Zinal S. Chheda, Hideho Okada
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (21): 5198–5205.
https://doi.org/10.1158/1078-0432.CCR-17-2769
Published: 01 November 2018
View article titled, Immunotherapy of Primary Brain Tumors: Facts and Hopes
Open the PDF for Immunotherapy of Primary Brain Tumors: Facts and Hopes in another window
Journal Articles

Induction of Robust Type-I CD8+ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC

Hideho Okada, Lisa H. Butterfield, Ronald L. Hamilton, Aki Hoji, Masashi Sakaki, Brian J. Ahn, Gary Kohanbash, Jan Drappatz, Johnathan Engh, Nduka Amankulor, Mark O. Lively, Michael D. Chan, Andres M. Salazar, Edward G. Shaw, Douglas M. Potter, Frank S. Lieberman
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (2): 286–294.
https://doi.org/10.1158/1078-0432.CCR-14-1790
Published: 14 January 2015
View article titled, Induction of Robust Type-I CD8<sup>+</sup> T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC
Open the PDF for Induction of Robust Type-I CD8<sup>+</sup> T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC in another window
Includes: Supplementary data
Journal Articles

LOH in the HLA Class I Region at 6p21 Is Associated with Shorter Survival in Newly Diagnosed Adult Glioblastoma

Jacky T. Yeung, Ronald L. Hamilton, Koji Ohnishi, Maki Ikeura, Douglas M. Potter, Marina N. Nikiforova, Soldano Ferrone, Regina I. Jakacki, Ian F. Pollack, Hideho Okada
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (7): 1816–1826.
https://doi.org/10.1158/1078-0432.CCR-12-2861
Published: 02 April 2013
View article titled, LOH in the HLA Class I Region at 6p21 Is Associated with Shorter Survival in Newly Diagnosed Adult Glioblastoma
Open the PDF for LOH in the HLA Class I Region at 6p21 Is Associated with Shorter Survival in Newly Diagnosed Adult Glioblastoma in another window
Includes: Supplementary data
Journal Articles

Role of Type 1 IFNs in Antiglioma Immunosurveillance—Using Mouse Studies to Guide Examination of Novel Prognostic Markers in Humans

Mitsugu Fujita, Michael E. Scheurer, Stacy A. Decker, Heather A. McDonald, Gary Kohanbash, Edward R. Kastenhuber, Hisashi Kato, Melissa L. Bondy, John R. Ohlfest, Hideho Okada
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (13): 3409–3419.
https://doi.org/10.1158/1078-0432.CCR-10-0644
Published: 30 June 2010
View article titled, Role of Type 1 IFNs in Antiglioma Immunosurveillance—Using Mouse Studies to Guide Examination of Novel Prognostic Markers in Humans
Open the PDF for Role of Type 1 IFNs in Antiglioma Immunosurveillance—Using Mouse Studies to Guide Examination of Novel Prognostic Markers in Humans in another window
Includes: Supplementary data
Journal Articles

Systemic Inhibition of Transforming Growth Factor-β in Glioma-Bearing Mice Improves the Therapeutic Efficacy of Glioma-Associated Antigen Peptide Vaccines

Ryo Ueda, Mitsugu Fujita, Xinmei Zhu, Kotaro Sasaki, Edward R. Kastenhuber, Gary Kohanbash, Heather A. McDonald, Jay Harper, Scott Lonning, Hideho Okada
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (21): 6551–6559.
https://doi.org/10.1158/1078-0432.CCR-09-1067
Published: 02 November 2009
View article titled, Systemic Inhibition of Transforming Growth Factor-β in Glioma-Bearing Mice Improves the Therapeutic Efficacy of Glioma-Associated Antigen Peptide Vaccines
Open the PDF for Systemic Inhibition of Transforming Growth Factor-β in Glioma-Bearing Mice Improves the Therapeutic Efficacy of Glioma-Associated Antigen Peptide Vaccines in another window
Includes: Supplementary data
Journal Articles

Antigenic Profiling of Glioma Cells to Generate Allogeneic Vaccines or Dendritic Cell–Based Therapeutics

Jian Gang Zhang, Junichi Eguchi, Carol A. Kruse, German G. Gomez, Habib Fakhrai, Stephanie Schroter, Wenxue Ma, Neil Hoa, Boris Minev, Christina Delgado, H. Terry Wepsic, Hideho Okada, Martin R. Jadus
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (2): 566–575.
https://doi.org/10.1158/1078-0432.CCR-06-1576
Published: 25 January 2007
View article titled, Antigenic Profiling of Glioma Cells to Generate Allogeneic Vaccines or Dendritic Cell–Based Therapeutics
Open the PDF for Antigenic Profiling of Glioma Cells to Generate Allogeneic Vaccines or Dendritic Cell–Based Therapeutics in another window
Journal Articles

Identification of a Novel HLA-A*0201-restricted, Cytotoxic T Lymphocyte Epitope in a Human Glioma-associated Antigen, Interleukin 13 Receptor α2 Chain

Fumiyoshi Okano, Walter J. Storkus, William H. Chambers, Ian F. Pollack, Hideho Okada
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (9): 2851–2855.
Published: 01 September 2002
View article titled, Identification of a Novel HLA-A*0201-restricted, Cytotoxic T Lymphocyte Epitope in a Human Glioma-associated Antigen, Interleukin 13 Receptor α2 Chain
Open the PDF for Identification of a Novel HLA-A*0201-restricted, Cytotoxic T Lymphocyte Epitope in a Human Glioma-associated Antigen, Interleukin 13 Receptor α2 Chain in another window